Skip to content
Urban Super Group

Zimbabwe Turns Down ‘One-Sided’ American Healthcare Assistance Package Due to Information Concerns

Medical funding illustration
The offered American financial assistance would have supported initiatives for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has turned down a significant American healthcare agreement worth $367m (272 million pounds) spanning five years over Washington's insistence on confidential data.

This rejection became public after a government memo from December was disclosed, revealing that President Emmerson Mnangagwa felt the deal was "lopsided".

A government representative later stated that the United States was seeking genetic material for research and commercial purposes while refused to guarantee the resulting advantages from any future treatments.

"We will now turn to the challenging and unfortunate process of winding down our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy noted the US had donated over $1.9bn as health assistance to Zimbabwe over the last twenty years.

A medical body in Zimbabwe has appealed for further talks to reach a agreement acceptable to all parties so the country's vital HIV treatment initiative can proceed.

Broader Background

This development comes after a similar situation in neighbouring Kenya, where a high court blocked a similar deal with the US after concerns were raised about the security of citizens' medical information.

After resuming office last year, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).

The agency had overseen assistance for the US government, but Trump claimed its spending was "inefficient" and his government was seeking direct bilateral agreements to boost transparency and accountability.

According to statements, 16 nations in Africa have to date agreed to similar health pacts, constituting over $18.3bn of fresh investment.

Details of the Declined Deal

This assistance for Zimbabwe would have supported "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this collaboration might have yielded significant advantages for Zimbabwean communities, particularly the 1.2 million presently on antiretroviral therapy through American-funded initiatives," Tremont added.

However, government spokesperson Nick Mangwana maintained the arrangement was "unfair".

"Zimbabwe was being asked to surrender its genetic material and health information indefinitely, without any equivalent guarantee of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could result from that shared data," he stated.

"Put simply, our country would supply the basic resources for scientific discovery with no assurance that the end products would be available to our population if a new health crisis arise."

Sovereignty and Global Health

Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral health agreements were upending structures previously set up through the international health agency.

Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to deal with potential pandemics.

"This framework is designed to guarantee that when a country contributes its data, the benefits – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the resources to develop them."

The government's concerns over the US deal "are not meant as opposition to America," Mangwana stressed.

"We encourage continued dialogue with our US partners on how future collaboration could be structured in a manner that honours the independence and interests of both nations."

Health Experts Reaction

A leading public health body said it acknowledged the official position, but suggested that negotiations must proceed given that much of the country's HIV programmes relied on foreign aid.

"If technical issues arise, such as those involving data governance or implementation frameworks, these can frequently be resolved via technical clarification and negotiated safeguards," the group said.

The halted deal underscores the continuing debate between accepting crucial international aid and safeguarding a country's data in an ever more data-driven world.

The writer

Ashley Butler

Eleanor Hartwell is an urban planner and writer passionate about sustainable communities and city innovation.

Urban Super Group

Type to search articles.